Skip to main content

StrongRoom AI

Category: AI in Healthcare

AI-driven medication management platform designed to reduce adverse drug events in healthcare settings through controlled drugs management StrongRoom AI was founded in 2017. The company is led by Joe Zhou (Current Owner) - Max Mito (Former CEO, suspended). Based in Melbourne, Australia. Team size: N/A. Total funding raised: $17 million. Latest round: Venture Round (March 2024). Key investors include EVP (Lead investor, $10.4M), Kalytix, Artesian Venture Partners, InterValley Ventures, Tyson & Blake.

Founded
2017
Headquarters
Melbourne, Australia
Team size
N/A
Total funding
$17 million

Value proposition

To enhance patient safety and streamline medication management through software that provides continuous analytics, workflow automation, and data safeguarding

Products and solutions

StrongER (Electronic Controlled Drug Register), StrongCare (e-Prescribing and Administration), StrongPro (Patient Loyalty & Medication Adherence), StrongShield (Cybersecurity)

Unique value

Former AI-driven medication management with facial recognition technology for controlled drug distribution - company collapsed in 2025

Target customer

Pharmacies, hospitals, and aged care facilities

Industries served

Healthcare, Pharmaceuticals, Aged Care

Technology advantage

Previously offered comprehensive software suite for healthcare medication management and compliance - current status unknown

How they differentiate

Previously differentiated through AI-driven medication management workflows, but competitive position severely damaged by company collapse

Main competitors

BESTmed, Fred IT Group, Simple Retail

Key partnerships

CyberQ Group (StrongShield), Various pharmacy chains in Australia and UK

Notable customers

Centennial Management Group, Various pharmacy chains

Major milestones

Assets sold to Joe Zhou for $3 million in June 2025 after collapse, Previously raised $17M at $70M valuation, Company faced fraud allegations from lead investor EVP, Placed in receivership March 2025, Co-founders involved in ongoing legal proceedings

Growth metrics

Company served over 1,500 customers in Australia and UK before collapse

Market positioning

Company suffered catastrophic collapse in 2025 with assets sold at fraction of previous valuation

Geographic focus

Primarily Australia, with some UK presence - current market position severely diminished

Patents and IP

Not publicly available - company faced IP-related legal issues during collapse

About Joe Zhou (Current Owner) - Max Mito (Former CEO, suspended)

Max Mito (Former CEO): Co-Founder 2017-2025, previously Co-Founder of Mito Heuston Group property development company. Led company through $17M funding round but faced fraud allegations. Currently suspended and involved in legal proceedings.

Official website: